Digitalis purpurea range of colours from white through pink to purple, such as "Dalmatian Purple". Cultivated forms often show flowers completely surrounding the central spike, in contrast to the wild form, where the flowers only appear on one side. "D. purpurea" is easily grown from seed or purchased as potted plants in the spring. The following selections have gained the Royal Horticultural Society's Award of Garden Merit: "Digitalis purpurea" is hardy to zones 4-9. Digoxigenin (DIG) is a steroid found exclusively in the flowers and leaves of the plants "Digitalis purpurea" and "Digitalis lanata". It is used as a molecular probe to
New Drug Application Review should complete within 6 months. The decision comes in a "Complete Response Letter". Biologics, such as vaccines and many recombinant proteins used in medical treatments are generally approved by FDA via a Biologic License Application (BLA), rather than an NDA. The manufacture of biologics is considered to differ fundamentally from that of less complex chemicals, requiring a somewhat different approval process. Generic drugs that have already been approved via an NDA submitted by another maker are approved via an Abbreviated New Drug Application (ANDA), which does not require all of the clinical trials normally required for a new drug